Shelly hyperlipidemia
Download as PPT, PDF3 likes3,096 views
This document provides information on hyperlipidemia including the transport and metabolism of lipids, causes of hyperlipidemia, screening guidelines, treatment goals, and treatment options. It describes how chylomicrons transport dietary fats through the lymphatic system to the liver where they are converted to LDL, which transports cholesterol to cells. HDL transports excess cholesterol from cells back to the liver. It lists various genetic and acquired causes of elevated lipids and guidelines for screening and treatment targets based on cardiovascular risk factors. Lifestyle modifications and drug classes used to treat hyperlipidemia are also summarized.
Shelly hyperlipidemia
- 1. Hyperlipidemia Michele Ritter, M.D. Argy Resident – February, 2007
- 2. The story of lipids Chylomicrons transport fats from the intestinal mucosa to the liver In the liver, the chylomicrons release triglycerides and some cholesterol and become low-density lipoproteins (LDL). LDL then carries fat and cholesterol to the body’s cells. High-density lipoproteins (HDL) carry fat and cholesterol back to the liver for excretion.
- 3. The story of lipids (cont.) When oxidized LDL cholesterol gets high, atheroma formation in the walls of arteries occurs, which causes atherosclerosis. HDL cholesterol is able to go and remove cholesterol from the atheroma. Atherogenic cholesterol → LDL, VLDL, IDL
- 5. Causes of Hyperlipidemia Diet Hypothyroidism Nephrotic syndrome Anorexia nervosa Obstructive liver disease Obesity Diabetes mellitus Pregnancy Obstructive liver disease Acute heaptitis Systemic lupus erythematousus AIDS (protease inhibitors)
- 6. Dietary sources of Cholesterol Type of Fat Main Source Effect on Cholesterol levels Monounsaturated Olives, olive oil, canola oil, peanut oil, cashews, almonds, peanuts and most other nuts; avocados Lowers LDL, Raises HDL Polyunsaturated Corn, soybean, safflower and cottonseed oil; fish Lowers LDL, Raises HDL Saturated Whole milk, butter, cheese, and ice cream; red meat; chocolate; coconuts, coconut milk, coconut oil , egg yolks, chicken skin Raises both LDL and HDL Trans Most margarines; vegetable shortening; partially hydrogenated vegetable oil; deep- fried chips; many fast foods; most commercial baked goods Raises LDL
- 7. Hereditary Causes of Hyperlipidemia Familial Hypercholesterolemia Codominant genetic disorder, coccurs in heterozygous form Occurs in 1 in 500 individuals Mutation in LDL receptor, resulting in elevated levels of LDL at birth and throughout life High risk for atherosclerosis, tendon xanthomas (75% of patients), tuberous xanthomas and xanthelasmas of eyes. Familial Combined Hyperlipidemia Autosomal dominant Increased secretions of VLDLs Dysbetalipoproteinemia Affects 1 in 10,000 Results in apo E2, a binding-defective form of apoE (which usually plays important role in catabolism of chylomicron and VLDL) Increased risk for atherosclerosis, peripheral vascular disease Tuberous xanthomas, striae palmaris
- 8. Checking lipids Nonfasting lipid panel measures HDL and total cholesterol Fasting lipid panel Measures HDL, total cholesterol and triglycerides LDL cholesterol is calculated: LDL cholesterol = total cholesterol – (HDL + triglycerides/5)
- 9. When to check lipid panel Two different Recommendations Adult Treatment Panel (ATP III) of the National Cholesterol Education Program (NCEP) Beginning at age 20: obtain a fasting (9 to 12 hour) serum lipid profile consisting of total cholesterol, LDL, HDL and triglycerides Repeat testing every 5 years for acceptable values United States Preventative Services Task Force Women aged 45 years and older, and men ages 35 years and older undergo screening with a total and HDL cholesterol every 5 years. If total cholesterol > 200 or HDL <40, then a fasting panel should be obtained Cholesterol screening should begin at 20 years in patients with a history of multiple cardiovascular risk factors, diabetes, or family history of either elevated cholesteral levels or premature cardiovascular disease.
- 10. Goals for Lipids LDL < 100 →Optimal 100-129 → Near optimal 130-159 → Borderline 160-189→ High ≥ 190 → Very High Total Cholesterol < 200 → Desirable 200-239 → Borderline ≥240 → High HDL < 40 → Low ≥ 60 → High Serum Triglycerides < 150 → normal 150-199 → Borderline 200-499 → High ≥ 500 → Very High
- 11. Determining Cholesterol Goal (LDL!) Look at JNC 7 Risk Factors Cigarette smoking Hypertension (BP ≥140/90 or on anti- hypertensives) Low HDL cholesterol (< 40 mg/dL) Family History of premature coronary heart disease (CHD) (CHD in first-degree male relative <55 or CHD in first-degree female relative < 65) Age (men ≥ 45, women ≥ 55)
- 12. Determining Goal LDL CHD and CHD Risk Equivalents: Peripheral Vascular Disease Cerebral Vascular Accident Diabetes Mellitus
- 13. LDL Goals 0-1 Risk Factors: LDL goal is 160 If LDL ≥ 160: Initiate TLC (therapeutic lifestyle changes) If LDL ≥ 190: Initiate pharmaceutical treatment 2 + Risk Factors LDL goal is 130 If LDL ≥ 130: Initiate TLC If LDL ≥ 160: Initiate pharmaceutical treatment CHD or CHD Risk Equivalent LDL goal is 100 (or 70) If LDL ≥ 100: Initiate TLC and pharmaceutical treatment
- 14. Treatment of Hyperlipidemia Lifestyle modification Low-cholesterol diet Exercise
- 15. Medications for Hyperlipidemia Drug Class Agents Effects (% change) Side Effects HMG CoA reductase inhibitors Lovastatin Pravastatin ↓LDL (18-55),↑ HDL (5-15) ↓ Triglycerides (7-30) Myopathy, increased liver enzymes Cholesterol absorption inhibitor Ezetimibe ↓ LDL( 14-18), ↑ HDL (1-3) ↓Triglyceride (2) Headache, GI distress Nicotinic Acid ↓LDL (15-30), ↑ HDL (15-35) ↓ Triglyceride (20-50) Flushing, Hyperglycemia, Hyperuricemia, GI distress, hepatotoxicity Fibric Acids Gemfibrozil Fenofibrate ↓LDL (5-20), ↑HDL (10-20) ↓Triglyceride (20-50) Dyspepsia, gallstones, myopathy Bile Acid sequestrants Cholestyramine ↓ LDL ↑ HDL No change in triglycerides GI distress, constipation, decreased absorption of other drugs
- 17. Case # 1 A 55-year-old woman without symptoms of CAD seeks assessment and advice for routine health maintenance. Her blood pressure is 135/85 mm Hg. She does not smoke or have diabetes and has been postmenopausal for 3 years. Her BMI is 24. Lipoprotein analysis shows a total cholesterol level of 240 mg/dL, an HDL level of 55 mg/dL, a triglyceride level of 85 mg/dL and a LDL level is 180 mg/dL. The patient has no family history of premature CAD.
- 18. Case # 1 (cont.) What is the goal LDL in this woman? What would you do if exercise/diet change do not improve cholesterol after 3 months? How would your management change if she complained of claudication with walking?
- 19. Case # 2 A 40- year-old man without significant past medical history comes in for a routine annual exam. He has no complaints but is worried because his father had a “heart attack” at the age of 45. He is a current smoker and has a 23-pack year history of tobacco use. A fasting lipid panel reveals a LDL 170 mg/dL and an HDL of 35 mg/dL. Serum Triglycerides were 140 mg/dL. Serum chemistries including liver panel are all normal.
- 20. Case # 2 (cont.) What is this patient’s goal LDL? Would you start medication, and if so, what?
- 21. Case # 3 A 65 year-old woman with medical history of Type II diabetes, obesity, and hypertension comes to your office for the first time. She has been told her cholesterol was elevated in the past and states that she has been following a “low cholesterol diet” for the past 6 months after seeing a dietician. She had a normal exercise stress test last year prior to knee replacement surgery and has never had symptoms of CHD. A fasting lipid profile was performed and revealed a LDL 130, HDL 30 and a total triglyceride of 300. Her Hgba1c is 6.5%.
- 22. Case # 3 (cont.) What is this patient’s goal LDL? What medication would you consider starting in this patient? What labs would you want to monitor in this patient?